The Effects of modified-release fampridine on upper limb impairment in multiple sclerosis

被引：0
|
作者：
Simpson, M. [1 ]
Churilov, L. [2 ]
Bardsley, B. [1 ]
Heriot, E. [1 ]
Dimovitis, J. [1 ]
Carey, L. [3 ]
Macdonell, R. [1 ]
机构：
[1] Univ Melbourne, Austin Hlth, Melbourne, Vic, Australia
[2] Univ Melbourne, Stat, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1294
引用
收藏
页码：685 / 685
页数：1
相关论文
共 50 条
  • [41] Importance of upper limb function in advanced multiple sclerosis
    Thomson, A.
    Giovannoni, G.
    Marta, M.
    Gnanpavan, S.
    Turner, B.
    Baker, D.
    Schmierer, K.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 676 - 676
  • [42] Neurophysiological correlates of upper limb function in multiple sclerosis
    Skoric, M. Krbot
    Gabelic, T.
    Malojcic, B.
    Lakusic, D. Mahovic
    Lisak, M.
    Barun, B.
    Crnosija, L.
    Habek, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 153 - 153
  • [43] Effects of prolonged-release fampridine on leg muscle activity during treadmill walking in individuals with multiple sclerosis (FAMPKIN)
    Loerincz, L.
    Zoerner, B.
    Weller, D.
    Reuter, K.
    Kapitza, S.
    Farkas, M.
    Sutter, T.
    Filli, L.
    Linnebank, M.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 608 - 608
  • [44] Treatment effects of fampridine on ambulation and upper extremity function in patients with multiple sclerosis from a real-world evidence cohort
    Kaya, L.
    van Munster, C. E. P.
    Lam, K. -H.
    Kalkers, N. F.
    Killestein, J.
    Uitdehaag, B.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 720 - 721
  • [45] Sustained release oral fampridine in the treatment of multiple sclerosis (vol 10, pg 2025, 2009)
    Kachuck, N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (14) : 2393 - 2393
  • [46] Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern
    Zoerner, Bjoern
    Filli, Linard
    Reuter, Katja
    Kapitza, Sandra
    Loerincz, Lilla
    Sutter, Tabea
    Weller, David
    Farkas, Melinda
    Easthope, Christopher S.
    Czaplinski, Adam
    Weller, Michael
    Linnebank, Michael
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (11) : 1463 - 1475
  • [47] Effects of Fampridine in People with Multiple Sclerosis: A Systematic Review and Meta-analysis
    Maxime Valet
    Mélanie Quoilin
    Thierry Lejeune
    Gaëtan Stoquart
    Vincent Van Pesch
    Souraya El Sankari
    Christine Detrembleur
    Thibault Warlop
    CNS Drugs, 2019, 33 : 1087 - 1099
  • [48] Interhemispherical predictors of disability and upper limb motor impairment in patients with multiple sclerosis: A structural and functional MRI study
    Cordani, Claudio
    Valsasina, Paola
    Meani, Alessandro
    Pagani, Elisabetta
    Morozumi, Tetsu
    Preziosa, Paolo
    Filippi, Massimo
    Rocca, Maria
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [49] Assessing visually guided reaching in people with multiple sclerosis with and without self-reported upper limb impairment
    Wijeyaratnam, Darrin O.
    Edwards, Thomas
    Pilutti, Lara A.
    Cressman, Erin K.
    PLOS ONE, 2022, 17 (01):
  • [50] THE EFFECTS OF FAMPRIDINE ON EYE MOVEMENTS IN MULTIPLE SCLEROSIS PATIENTS WITH INTERNUCLEAR OPHTHALMOPLEGIA.
    Kanhai, K.
    Wagenaar, Y. L.
    Bijvank, J. A. Nij
    Klaassen, E. S.
    Lim, K.
    Bergheanu, S. C.
    Petzold, A.
    Verma, A.
    van Rijn, R.
    Groeneveld, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S32 - S33
12345